IL-17A+, IL-22+, and IL-23+ immunoreactive cells are increased in bronchial biopsies of patients with stable COPD compared to control subjects (Di Stefano et al., 2009). This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.